Diabetes and Markets for Diabetes Care: Double Blind Tests and Other Controversies
‘Diabetes and Markets for Diabetes Care’: A Criticism from an Empirical Viewpoint. 1. Introduction 1-1. Definitions of Diseases Evolve 1-2. Diabetes Cannot Be Misdiagnosed. 1-3. A Name Tells Many Things 2. Inherent Complexity and Methodological Difficulties in Type II Diabetes researches. 2-1. We Have Infinitely Complex Bodies. 2-2. Dismal Science vs. Witchcraft 2-3. …
Diabetes and Markets for Diabetes Care: Double Blind Tests and Other Controversies Read More »